Page 2 of 12 – SEC Filing
| CUSIP No. 92672L107 | ||||
| 1 | NAME OF REPORTING PERSON OrbiMed Advisors LLC | |||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ☐ (b) ☐ | ||
| 3 | SEC USE ONLY | |||
| 4 | SOURCE OF FUNDS AF | |||
| 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | ||
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | ||
| 8 | SHARED VOTING POWER 9,866,102(1) | |||
| 9 | SOLE DISPOSITIVE POWER 0 | |||
| 10 | SHARED DISPOSITIVE POWER 9,866,102(1) | |||
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,866,102(1) | |||
| 12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) | ☐ | ||
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 17.7% (2) | |||
| 14 | TYPE OF REPORTING PERSON (See Instructions) IA | |||
| (1) | Includes (i) 9,458,567 outstanding shares of common stock, par value $0.01 per share (the “Shares”), of ViewRay, Inc., a Delaware corporation (the “Issuer”), and (ii) 407,535 Shares issuable upon the exercise of warrants to purchase shares (the “Warrants”). |
| (2) | This percentage is calculated based upon 55,489,939 Shares outstanding of the Issuer, as set forth in the Issuer’s Form 10-K, filed with the Securities and Exchange Commission on March 17, 2017, and includes an additional 407,535 Shares subject to currently exercisable Warrants held by the Reporting Persons. |
Follow Viewray Inc. (NASDAQ:VRAY) Follow Viewray Inc. (NASDAQ:VRAY)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
